The advent of FDA approved anti-AB drugs such as Aducanumab and Lecanemab is changing not only the therapeutic prospectives for patients but also the diagnostic flow-charts. However, due to differences in clinical processes and insurance systems in each country, the use of amyloid PET in the diagnostic tree currently varies from country to country. In Europe, […]
With the arrival of new therapeutic tracers, nuclear medicine has a new arsenal to treat metastatic bone pain. This presentation aims to give the keys to define the place of nuclear medicine among other treatment modalities (external beam therapy, medical treatment, chemotherapy). Learning Objectives: Refresh knowledge on the pathophysiology of pain and present the opportunities […]
The webinar primarily focuses on the clinical value and implementation of early phase SPECT-CT in non-oncological settings, emphasizing its advantages over traditional planar imaging and late-phase bone scans. It highlights the diagnostic enhancement of early-phase imaging for inflammatory conditions, pain assessment, and soft-tissue evaluation. New treatment options for cardiac amyloidosis are increasing interest in early […]
Neuroendocrine tumours (NETs) are a rare but clinically significant group of malignancies arising from neuroendocrine cells, often presenting in the gastrointestinal tract or lungs. While NETs account for a small fraction of overall cancer cases, their incidence is steadily rising. Radioguided surgery has emerged as a highly effective approach for treating NETs, particularly in cases […]
Long axial field of view (LAFOV) PET/CT is the latest development in PET instrumentation. This webinar will provide an overview of the clinical opportunities and applications of LAFOV PET in inflammation and infection imaging. Learning Objectives Target Audience Faculty Event Overview
This webinar aims to introduce the concept of theranostics and provide an overview of its potential. Participants will gain an understanding of how our technological competencies contribute to and enhance theranostic processes, and how we can leverage these strengths in practice. Please note that the webinar will be recorded, and the recording will be available […]
This webinar explores the perspectives on radiorefractory thyroid cancer through two presentations. In the first talk the speaker challenges current diagnostic frameworks and proposes a new vision that better reflects the evolving understanding of refractory thyroid cancer. The second presentation offers a comprehensive review of emerging approaches to restore iodine avidity in radiorefractory thyroid cancer, […]
more information coming soon Faculty Event Overview
This course presents and discusses the requirements and methods to enable and perform personalized dosimetry in nuclear medicine therapy. Learning Objectives The aim of this course is to provide tools and methods to implement personalized dosimetry in a clinical setup. Target Audience Nuclear medicine clinicians and medical physicists Suggested Readings "EANM enabling guide: how to […]
This webinar provides an overview of the diagnosis of cardiac amyloidosis in nuclear cardiology . Background information on amyloidosis in general is presented and typical disease manifestations are discussed. Furthermore, the significance of cardiac amyloidosis will be discussed in detail and possible therapeutic options will be explained. In this context, the relevance of quantification to […]
In nuclear medicine, diagnostic as well as therapeutic, radiopharmaceuticals are administered via an intravenous injection, in a majority of the procedures in a blood vessel at the crook of the arm or on the back of the hand. Occasionally, the injection fails, which results in the radiopharmaceutical ending up extravascularly. The consequence of this may […]
The purpose of this seminar is to provide a comprehensive overview of radionuclide therapy using alpha-emitting isotopes, focusing on their current clinical and preclinical applications. It will explore the unique advantages of alpha emitters, such as their high linear energy transfer and short path length, which allow for precise tumor cell killing with minimal damage […]
European School of Multimodality Imaging & Therapy (ESMIT)
Schmalzhofgasse 26
1060 Vienna
Austria
phone +43 1 890 44 27
e-mail esmit@eanm.org
